This article explores an engaging debate from the European Society of Cardiology (ESC) Congress 2025, which addresses the position of renal denervation (RDN) for uncontrolled and resistant hypertension in patients who should be referred to specialist centres. The article also covers a poster session reporting on a systematic review and meta-analysis that investigated the therapeutic effects of RDN beyond hypertension.
